1
|
Petit L, Pastene B, Dupont G, Baffeleuf B, Goulevant PA, Fellahi JL, Gricourt Y, Lebuffe G, Ouattara A, Fischer MO, Mertes PM, Eyraud D, Bouhemad B, Gomola A, Montravers P, Alingrin J, Flory L, Incagnoli P, Boisson M, Leone M, Monneret G, Lukaszewicz AC, Pereira B, Molliex S. Postoperative lymphopaenia as a risk factor for postoperative infections in cancer surgery: A prospective multicentre cohort study (the EVALYMPH study). Eur J Anaesthesiol 2025; 42:244-254. [PMID: 39474711 DOI: 10.1097/eja.0000000000002089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2025]
Abstract
BACKGROUND Stress due to surgical trauma decreases postoperative lymphocyte counts (LCs), potentially favouring the occurrence of postoperative infections (PIs). OBJECTIVES We aimed to determine whether postoperative lymphopaenia following thoracic or gastrointestinal cancer surgery is an independent risk factor for PIs and to identify modifiable factors related to anaesthesia and surgical procedures that might affect its occurrence. STUDY DESIGN The EVALYMPH study was a prospective, multicentre cohort study with a 30-day patient follow-up. Multivariate analyses were performed to determine the risk factors for PIs and for postoperative lymphopaenia. SETTING Patients were included from January 2016 to September 2017 in 25 French centres. PATIENTS Adult patients admitted for thoracic or gastrointestinal cancer surgery were eligible for inclusion. MAIN OUTCOME MEASURE PIs within 30 days after surgery were defined as urinary tract infections, pneumonia, surgical site infections and other infections (bloodstream infections or pleurisy). RESULTS Of 1207 patients included, 273 (22.6%) developed at least one infection within 30 days after surgery, with a median [IQR] time to onset of 8 [5 to 11] days. An increased risk of PI was significantly associated with an ASA score of IV: hazard ratio (HR) 4.27 (95% confidence interval (CI), 1.87 to 9.72), surgery > 200 min (HR 1.58 (1.15 to 2.17) and lymphopaenia on postoperative day 1 (POD1) (HR 1.56 (1.08 to 2.25). This risk was associated with changes in postoperative LC over time ( P = 0.001) but not with preoperative LC ( P = 0.536).POD1 lymphopenia was related to patient characteristics and duration of surgery but not to potentially modifiable other surgical or anaesthetics factors. CONCLUSIONS POD1 lymphopaenia was associated with PIs in patients undergoing thoracic or gastrointestinal cancer surgery. To individualise care, patient characteristics and surgery duration should be taken into account. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT02799251.
Collapse
Affiliation(s)
- Ludivine Petit
- From the Département d'Anesthésie-Réanimation, Université Jean Monnet Saint Etienne, CHU Saint Etienne, F-42023, Saint Etienne, France (LP, GD, LF SM), the Service d'Anesthésie et de Réanimation, Université d'Aix Marseille, Assistance Publique Hôpitaux de Marseille,, Hôpital Nord, Marseille, France (BP, JA, ML), the Département d'Anesthésie Réanimation, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France (BB, PI), the Service d'Anesthésie Réanimation & Médecine Péri-opératoire, Centre Hospitalier Universitaire de Poitiers, Poitiers, 86021, France; Inserm U1070, Université de Poitiers, Poitiers, France (PAG, MB), the Service d'Anesthésie et de Réanimation, Hôpital Universitaire Louis Pradel, Hospices Civils de Lyon, 69500, Lyon, France (JLF), the Département Anesthésie et Réanimation, Centre Hospitalier Universitaire Nîmes, Nîmes, France (YG), the Service d'Anesthésie, Centre hospitalier et universitaire de Lille, F-59037 Lille, France (GL), the Service Anesthésie et Réanimation, Centre Medico-chirurgical Magellan, Centre Hospitalier Universitaire de Bordeaux, Pessac, France (AO), the Département d'Anesthésie et de Réanimation, Centre Hospitalier Universitaire de Caen, Caen, France (MOF), Service d'Anesthésie-Réanimation Chirurgicale NHC - Hôpitaux Universitaires de Strasbourg, 67094 Strasbourg cedex, France (PMM), AP-HP, 26930, Groupe Hospitalier Universitaire APHP-Sorbonne Université, site Pitié-Salpêtrière, Département d'Anesthésie Réanimation, F-75013, Paris, Île-de-France, France (DE), the Département d'Anesthésie et de Réanimation, Centre Hospitalier Universitaire, Dijon, France (BB), the Département d'Anesthésie, Réanimation et Médecine Périopératoire, Groupe Hospitalier Universitaire Cochin, Paris, France (AG), AP-HP Nord, the Département d'Anesthésie Réanimation, CHU Bichat-Claude-Bernard, Paris, France. Université Paris-Cité, France (PM), the Laboratoire d'immunologie et EA7426, Hospices Civils de Lyon, Groupement Hospitalier Edouard Herriot, Lyon, France (GM), the Département d'Anesthésie et de Réanimation, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France (ACL), Direction de la Recherche Clinique, Centre Hospitalier Universitaire de Clermont-Ferrand, Unité de Biostatistiques, Clermont-Ferrand, France (BP)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Ma Y, Ren J, Chen Z, Chen J, Wei M, Wang Y, Chen H, Wang L. Outcomes of intravenous and inhalation anesthesia on patients undergoing esophageal cancer surgery: a retrospective observational study. BMC Anesthesiol 2023; 23:66. [PMID: 36864402 PMCID: PMC9979524 DOI: 10.1186/s12871-023-02023-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2022] [Accepted: 02/17/2023] [Indexed: 03/04/2023] Open
Abstract
BACKGROUND Different anesthetics may have opposite effects on the immune system, thus affecting the prognosis of tumor patients. Cell-mediated immunity forms the primary defense against the invasion of tumor cells, so manipulation of the immune system to produce an enhanced anti-tumor response could be utilized as an adjuvant oncological therapy. Sevoflurane has proinflammatory effects, while propofol, has anti-inflammatory and antioxidant effects. Therefore, we compared the overall survival (OS) and disease-free survival (DFS) of patients with esophageal cancer under total intravenous anesthesia and inhalation anesthesia. METHODS This study collected the electronic medical records of patients undergoing esophagectomy from January 1, 2014 to December 31, 2016. According to the intraoperative anesthetics, the patients were divided into total intravenous anesthesia (TIVA) group or inhalational anesthesia (INHA) group. Stabilized inverse probability of treatment weighting (SIPTW) was used to minimize differences. Kaplan-Meier survival curve was established to evaluate the correlation between different anesthesia methods in overall survival and disease-free survival of patients undergoing esophageal cancer surgery. RESULTS A total of 420 patients with elective esophageal cancer were collected, including 363 patients eligible for study (TIVA, n = 147, INHA, n = 216). After SIPTW there were no significant differences between two groups in overall survival and disease-free survival. However, the adjuvant therapy was statistically significant in improving OS, and the degree of differentiation was correlated with OS and DFS. CONCLUSIONS In conclusion, there were no significant difference in overall survival and disease-free survival between total intravenous anesthesia and inhalational anesthesia in patients undergoing esophageal cancer surgery.
Collapse
Affiliation(s)
- Yue Ma
- Department of Anesthesiology, Harbin Medical University Cancer Hospital, No. 150 Haping Rd., Nangang District, Harbin, 150081, China
| | - Jie Ren
- Department of Anesthesiology, Guizhou Provincial People's Hospital, No. 83 Zhongshan East Road, Nanming District, Guiyang, 550002, Guizhou, China
| | - Zhuo Chen
- Department of Anesthesiology, Harbin Medical University Cancer Hospital, No. 150 Haping Rd., Nangang District, Harbin, 150081, China
| | - Jingwen Chen
- Department of Anesthesiology, Harbin Medical University Cancer Hospital, No. 150 Haping Rd., Nangang District, Harbin, 150081, China
| | - Ming Wei
- Department of Anesthesiology, Harbin Medical University Cancer Hospital, No. 150 Haping Rd., Nangang District, Harbin, 150081, China
| | - Yu Wang
- Department of Anesthesiology, Harbin Medical University Cancer Hospital, No. 150 Haping Rd., Nangang District, Harbin, 150081, China.
| | - Hong Chen
- Department of Anesthesiology, Harbin Medical University Cancer Hospital, No. 150 Haping Rd., Nangang District, Harbin, 150081, China.
| | - Liping Wang
- Department of Anesthesiology, Harbin Medical University Cancer Hospital, No. 150 Haping Rd., Nangang District, Harbin, 150081, China.
| |
Collapse
|